The supplements marketed as Enzogenol by ENZO Nutraceuticals, comprise flavonoids and other plant polyphenols with antioxidant and natural anti-inflammatory properties.
A pilot study led by the director of AUT’s National Institute for Stroke and Applied Neuroscience, Professor Valery Feigin involved sixty people with persistent cognitive difficulties due to TBI.
The subjects were given Enzogenol for either a six or 12 week period, who showed an improvement in day-to-day cognitive functioning.
The study was intended to investigate the efficacy of Enzogenol to improve verbal and working memory, information processing speed, attention span, everyday memory difficulties and post-concussive symptoms in patients three to 12 months following mild TBI.